RE:These 2-3 bashers (fake accounts)That is rich coming from "NewStockyJohnson" and as far as $50+ by EOY I think you better put down that crack pipe.
I think the most recent analyst nailed it on their 12 month price target of $9.20 CAD with no material news, projected delays and the suggested need for future financing all I see here is dead to deteriorating money for the rest of the year at a minimum. Delays will result in further increasing opportunity costs for shareholders.
Even when they finally submit the BLA I don't think it substantially moves the share price needle vs actually obtaining FDA approval/Partnership which looks now to be deep into 2021 at the earliest and by that time they will be hanging by the same debt rope they were in before.